IMMUNOGENES
ImmunoGenes is a biotech company with a platform technology that improves the immune response using genetically-modified mice and rabbits that overexpress the neonatal Fc receptor (FcRn). Their IMG-AbS:tm: patented technology results in a greater number and greater diversity of B cell clones than is typical and a strong immune response against weakly immunogenic targets. This, in turn, generates high-quality monoclonal antibody candidates with high affinity and diversity that pharmaceutical and ... biotech companies can use in their development of unique therapeutics and diagnostics. ImmunoGenes discovers and develops its antibody drugs in collaboration with pharmaceutical, institutional and academic partners. They are employing their proprietary technologies, including IMG-Abs:tm: to discover, develop and commercialise monoclonal antibodies to difficult and novel targets.
IMMUNOGENES
Social Links:
Industry:
Biotechnology Medical
Founded:
2007-01-01
Address:
Budakeszi, Pest, Hungary
Country:
Hungary
Website Url:
http://www.immunogenes.com
Total Employee:
1+
Status:
Active
Contact:
+36-30-757-7870
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Apache
Similar Organizations
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Current Advisors List
Investors List
Texas HALO Fund
Texas HALO Fund investment in Series A - ImmunoGenes
Official Site Inspections
http://www.immunogenes.com
- Host name: s7.mcvps.hu
- IP address: 92.43.203.149
- Location: Hungary
- Latitude: 47.4919
- Longitude: 19.05
- Timezone: Europe/Budapest
